Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

New hypolipidemic agent from Schering-Plough

Aug. 23, 1996

Metachol distribution agreement

Aug. 23, 1996

Eisai's squalene synthase inhibitor and prodrug

Aug. 23, 1996

Yamanouchi and PT CarbaPharma describe cathepsin L inhibitor

Aug. 23, 1996

Indian hedgehog molecule's role in cartilage and bone development

Aug. 23, 1996

Osteocalcin study findings reported

Aug. 23, 1996

Aredia earns U.S. approval for new indication

Aug. 23, 1996

Conceptus reports clinical advances with S/TOP system

Aug. 16, 1996

Zonagen initiates pivotal trials of Vasomax

Aug. 16, 1996

Andropatch marketed in U.K.

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...